CHANTEST, INC.

Company Information

Company Name
CHANTEST, INC.
Address
14656 NEO PKY
CLEVELAND, OH, -
Phone
1 216-332-1665
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$487,784.00
5
SBIR Phase II
$1,764,756.00
2
Chart code to be here

Award List

  1. Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car

    Amount: $149,275.00

    DESCRIPTION (provided by applicant): Stem Cell-derived Human Cardiomyocytes (SC-hCMs) offer great potential for improving the accuracy of pre-clinical cardiac safety screening. We have recently charac ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. New drugs for treatment of atrial fibrillation

    Amount: $99,924.00

    Atrial fibrillation (AF) is the commonest cardiac arrhythmia and in its chronic form affects more than two million patients in the USA. AF is associated with cardiac and non-cardiac diseases. About 10 ...

    SBIR Phase I 2001 Department of Health and Human Services
  3. New drugs for treatment of atrial fibrillation

    Amount: $0.00

    DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most common cause of arrhythmias in the elderly; it has an incidence of more than 5 percent in people > 69 years of age. At present ...

    SBIR Phase I 2003 Department of Health and Human Services
  4. New drugs for treatment of atrial fibrillation

    Amount: $580,448.00

    DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most common cause of arrhythmias in the elderly; it has an incidence of more than 5 percent in people > 69 years of age. At present ...

    SBIR Phase II 2003 Department of Health and Human Services
  5. Development of a Complete Proarrhythmic Safety Profile for Drugs

    Amount: $149,322.00

    DESCRIPTION (provided by applicant): ChanTest's goal is to commercialize a comprehensive non-clinical proarrhythmic profile that will screen compounds through a battery of models that span from the mo ...

    SBIR Phase I 2006 Department of Health and Human Services
  6. NOVEL SIMPLE SCREEN FOR POTASSIUM CHANNELS

    Amount: $89,263.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  7. Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car

    Amount: $1,184,308.00

    DESCRIPTION (provided by applicant): Stem Cell-derived Human Cardiomyocytes (SC-hCMs) offer great potential for improving the accuracy of pre- clinical cardiac safety testing. We have characterized a ...

    SBIR Phase II 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government